The pharmacy supply chain is one of the most complex and opaque parts of the healthcare ecosystem. Co-pay discounts and other rebates may lower costs, but do not address the
Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee
April 18, 2019 The Council has joined over 30 other employment-based trade groups to provide two letters on the issue of surprise medical billing to House leadership, and the chair
April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can
Seventy-eight percent of Americans live paycheck to paycheck. People need help, and it’s one thing to read about it and another to understand what that means as a day-to-day situation
March 21, 2019 One in every two individuals born today will be diagnosed with cancer—a genetic disease—at some point during their lifetime. Nick Bellanca of Wamberg Genomic Advisors breaks down
March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to
March 21, 2019 A year after the three corporate giants announced plans to join forces, the ABJ venture unveiled its name: Haven. With 1.2 million covered employees and family members,
March 21, 2019 Rep. Pramila Jayapal’s (D-WA) bill, which calls for a rapid, two-year transition onto a public health plan, is the latest effort to transition the U.S. to a
March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on
